Cite

Fucharoen S, Winichagoon P. Thalassemia in SouthEast Asia: problems and strategy for prevention and control. Southeast Asian J Trop Med Public Health. 1992; 23:647-55.1298071FucharoenSWinichagoonP.Thalassemia in SouthEast Asia: problems and strategy for prevention and controlSoutheast Asian J Trop Med Public Health.19922364755Search in Google Scholar

Pansuwan A, Fucharoen G, Fucharoen S, Himakhun B, Dangwiboon S. Anemia, iron deficiency and thalassemia among adolescents in Northeast Thailand: results from two independent surveys. Acta Haematol. 2011; 125:186-92.2122856510.1159/000322666PansuwanAFucharoenGFucharoenSHimakhunBDangwiboonS.Anemia, iron deficiency and thalassemia among adolescents in Northeast Thailand: results from two independent surveysActa Haematol.20111251869221228565Search in Google Scholar

Borgna-Pignatti C, Gamberini MR. Complications of thalassemia major and their treatment. Expert Rev Hematol. 2011; 4:353-66.2166839910.1586/ehm.11.29Borgna-PignattiCGamberiniMR.Complications of thalassemia major and their treatmentExpert Rev Hematol.201143536621668399Search in Google Scholar

Gamberini MR, De Sanctis V, Gilli G. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. Pediatr Endocrinol Rev. 2008; 6 Suppl 1:158-69.19337172GamberiniMRDe SanctisVGilliG.Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara CentrePediatr Endocrinol Rev.20086Suppl 115869Search in Google Scholar

Al-Rimawi HS, Jallad MF, Amarin ZO, Al Sakaan R. Pubertal evaluation of adolescent boys with β-thalassemia major and delayed puberty. Fertil Steril. 2006; 86:886-90.10.1016/j.fertnstert.2006.02.11817027358Al-RimawiHSJalladMFAmarinZOAl SakaanR.Pubertal evaluation of adolescent boys with β-thalassemia major and delayed pubertyFertil Steril.2006868869017027358Open DOISearch in Google Scholar

De Sanctis V, Roos M, Gasser T, Fortini M, Raiola G, Galati MC. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia. J Pediatr Endocrinol Metab. 2006; 19:471-80.16759032De SanctisVRoosMGasserTFortiniMRaiolaGGalatiMC.Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemiaJ Pediatr Endocrinol Metab.20061947180Search in Google Scholar

Chern JP, Lin KH, Tsai WY, Wang SC, Lu MY, Lin DT, et al. Hypogonadotropic hypogonadism and hematologic phenotype in patients with transfusiondependent beta-thalassemia. J Pediatr Hematol Oncol. 2003; 25:880-4.10.1097/00043426-200311000-00011ChernJPLinKHTsaiWYWangSCLuMYLinDTHypogonadotropic hypogonadism and hematologic phenotype in patients with transfusiondependent beta-thalassemiaJ Pediatr Hematol Oncol.200325880414608198Open DOISearch in Google Scholar

Merchant RH, Shirodkar A, Ahmed J. Evaluation of growth, puberty and endocrine dysfunctions in relation to iron overload in multi transfused Indian thalassemia patients. Indian J Pediatr. 2011; 78:679-83.10.1007/s12098-010-0351-321234716MerchantRHShirodkarAAhmedJ.Evaluation of growth, puberty and endocrine dysfunctions in relation to iron overload in multi transfused Indian thalassemia patientsIndian J Pediatr.2011786798321234716Open DOISearch in Google Scholar

Soliman AT, elZalabany M, Amer M, Ansari BM. Growth and pubertal development in transfusiondependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study. J Trop Pediatr. 1999; 45:23-3010.1093/tropej/45.1.23SolimanATelZalabanyMAmerMAnsariBM.Growth and pubertal development in transfusiondependent children and adolescents with thalassaemia major and sickle cell disease: a comparative studyJ Trop Pediatr.199945233010191589Open DOISearch in Google Scholar

Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004; 89:1187-93.15477202Borgna-PignattiCRugolottoSDe StefanoPZhaoHCappelliniMDDel VecchioGCSurvival and complications in patients with thalassemia major treated with transfusion and deferoxamineHaematologica.200489118793Search in Google Scholar

Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, et al. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Eur J Haematol. 2005; 74:93-100.1565489810.1111/j.1600-0609.2004.00371.xShalitinSCarmiDWeintrobNPhillipMMiskinHKornreichLSerum ferritin level as a predictor of impaired growth and puberty in thalassemia major patientsEur J Haematol.2005749310015654898Search in Google Scholar

Papadimas J, Mandala E, Pados G, Kokkas B, Georgiadis G, Tarlatzis B, et al. Pituitary–testicular axis in men with β-thalassaemia major. Hum Reprod. 1996; 11:1900-4.10.1093/oxfordjournals.humrep.a0195158921062PapadimasJMandalaEPadosGKokkasBGeorgiadisGTarlatzisBPituitary–testicular axis in men with β-thalassaemia majorHum Reprod.199611190048921062Open DOISearch in Google Scholar

Bronspiegel-Weintrob N, Olivieri NF, Tyler B, Andrews DF, Freedman MH, Holland FJ. Effect of age at the start of iron chelation therapy on gonadal function in β-thalassemia major. N Engl J Med. 1990; 323:713-9.10.1056/NEJM1990091332311042388669Bronspiegel-WeintrobNOlivieriNFTylerBAndrewsDFFreedmanMHHollandFJ.Effect of age at the start of iron chelation therapy on gonadal function in β-thalassemia majorN Engl J Med.199032371392388669Open DOISearch in Google Scholar

Jensen CE, Tuck SM, Old J, Morris RW, Yardumian A, De Sanctis V, et al. Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia. Eur J Haematol. 1997; 59:76-81.9293854JensenCETuckSMOldJMorrisRWYardumianADe SanctisVIncidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemiaEur J Haematol.199759768110.1111/j.1600-0609.1997.tb00729.x9293854Search in Google Scholar

Grinspon RP, Rey RA. Anti-Müllerian hormone and Sertoli cell function in paediatric male hypogonadism. Horm Res Paediatr. 2010; 73:81-92.10.1159/00027714020190544GrinsponRPReyRA.Anti-Müllerian hormone and Sertoli cell function in paediatric male hypogonadismHorm Res Paediatr.201073819220190544Open DOISearch in Google Scholar

Grinspon RP, Loreti N, Braslavsky D, Bedecarras P, Ambao V, Gottlieb S, et al. Sertoli cell markers in the diagnosis of paediatric male hypogonadism. J Pediatr Endocrinol Metab. 2012; 25:3.GrinsponRPLoretiNBraslavskyDBedecarrasPAmbaoVGottliebSSertoli cell markers in the diagnosis of paediatric male hypogonadismJ Pediatr Endocrinol Metab.201225310.1515/jpem-2011-045322570945Search in Google Scholar

Matuszczak E, Hermanowicz A, Debek W, Oksiuta M, Dzienis-Koronkiewicz E, Zelazowska-Rutkowska B. Serum AMH concentration as a marker evaluating gonadal function in boys operated on for unilateral cryptorchidism between 1st and 4th year of life. Endocrine. 2012; 41:334-7.2203845210.1007/s12020-011-9551-5MatuszczakEHermanowiczADebekWOksiutaMDzienis-KoronkiewiczEZelazowska-RutkowskaB.Serum AMH concentration as a marker evaluating gonadal function in boys operated on for unilateral cryptorchidism between 1st and 4th year of lifeEndocrine.2012413347329865122038452Search in Google Scholar

Laporte S, Couto-Silva AC, Trabado S, Lemaire P, Brailly-Tabard S, Esperou H, et al. Inhibin B and anti-M llerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood. BMC Pediatr. 2011; 11:20.10.1186/1471-2431-11-20LaporteSCouto-SilvaACTrabadoSLemairePBrailly-TabardSEsperouHInhibin B and anti-M llerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhoodBMC Pediatr.20111120305804721352536Open DOISearch in Google Scholar

Guibourdenche J, Lucidarme N, Chevenne D, Rigal O, Nicolas M, Luton D, et al. Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Mol Cell Endocrinol. 2003; 211:55-63.1465647710.1016/j.mce.2003.09.011GuibourdencheJLucidarmeNChevenneDRigalONicolasMLutonDAnti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interestMol Cell Endocrinol.2003211556314656477Search in Google Scholar

Cuny A, Trivin C, Brailly-Tabard S, Adan L, Zerah M, Sainte-Rose C, et al. Inhibin B and antimüllerian hormone as markers of gonadal function after treatment for medulloblastoma or posterior fossa ependymoma during childhood. J Pediatr. 2011; 158:1016-22.e1.10.1016/j.jpeds.2010.11.01921168856CunyATrivinCBrailly-TabardSAdanLZerahMSainte-RoseCInhibin B and antimüllerian hormone as markers of gonadal function after treatment for medulloblastoma or posterior fossa ependymoma during childhoodJ Pediatr.2011158101622.e121168856Open DOISearch in Google Scholar

Canale VC, Steinherz P, New M, Erlandson M. Endocrine function in thalassemia major. Ann N Y Acad Sci. 1974; 232:333-45.436999010.1111/j.1749-6632.1974.tb20597.xCanaleVCSteinherzPNewMErlandsonM.Endocrine function in thalassemia majorAnn N Y Acad Sci.1974232333454369990Search in Google Scholar

eISSN:
1875-855X
Language:
English
Publication timeframe:
6 times per year
Journal Subjects:
Medicine, Assistive Professions, Nursing, Basic Medical Science, other, Clinical Medicine